F Murdoch1, J Danial2, A K Morris3, E Czarniak2, J L Bishop1, E Glass1, L J Imrie4. 1. Health Protection Scotland, NHS National Services Scotland, Glasgow, UK. 2. NHS Lothian, Royal Infirmary of Edinburgh, Edinburgh, UK. 3. NHS Fife, Victoria Hospital, Fife, UK. 4. Health Protection Scotland, NHS National Services Scotland, Glasgow, UK. Electronic address: nss.hpssab@nhs.net.
Abstract
BACKGROUND: National enhanced surveillance of Staphylococcus aureus bacteraemia (SAB) commenced on 1st October 2014 to gain a more in-depth understanding of the epidemiology of SAB in Scotland. Children under 16 years of age were analysed separately from adults because previous studies had demonstrated epidemiological differences. AIM: To identify risk factors and patient populations at greatest risk to enable the development of focused improvement plans. METHODS: All National Health Service (NHS) boards within NHS Scotland take part in the mandatory enhanced surveillance, with data collected by trained data collectors using nationally agreed definitions. FINDINGS: Analysis of the first 18 months of data showed that hospital-acquired SAB was mostly associated with neonates with device risk factors, whereas community-associated SAB was found in older children who had few, if any, risk factors and most presented with a bone or joint infection. CONCLUSION: The enhanced SAB data highlighted the difference in risk factors and entry points for the acquisition of SAB within the paediatric population. Crown
BACKGROUND: National enhanced surveillance of Staphylococcus aureus bacteraemia (SAB) commenced on 1st October 2014 to gain a more in-depth understanding of the epidemiology of SAB in Scotland. Children under 16 years of age were analysed separately from adults because previous studies had demonstrated epidemiological differences. AIM: To identify risk factors and patient populations at greatest risk to enable the development of focused improvement plans. METHODS: All National Health Service (NHS) boards within NHS Scotland take part in the mandatory enhanced surveillance, with data collected by trained data collectors using nationally agreed definitions. FINDINGS: Analysis of the first 18 months of data showed that hospital-acquired SAB was mostly associated with neonates with device risk factors, whereas community-associated SAB was found in older children who had few, if any, risk factors and most presented with a bone or joint infection. CONCLUSION: The enhanced SAB data highlighted the difference in risk factors and entry points for the acquisition of SAB within the paediatric population. Crown
Authors: Sarah Grace Gunter; Mary Joyce B Wingler; David A Cretella; Jamie L Wagner; Katie E Barber; Kayla R Stover Journal: Pharmacy (Basel) Date: 2022-01-15
Authors: Bibi C G C Slingerland; Margreet C Vos; Willeke Bras; René F Kornelisse; Dieter De Coninck; Alex van Belkum; Irwin K M Reiss; Wil H F Goessens; Corné H W Klaassen; Nelianne J Verkaik Journal: Antimicrob Resist Infect Control Date: 2020-02-22 Impact factor: 4.887